Search Results - "Modest, D.P."

Molecular Mechanisms of Liver Metastasis: Connecting Biology, Biomarkers, and Outcomes.

Authors: Wagner, Doris Balzer, Felix Margonis, Georgios Antonios

Source: Cells (2073-4409). Mar2026, Vol. 15 Issue 5, p469. 3p.

The Effects of Variant Allele Frequency for EGFR Mutation on Early Tumor Shrinkage and Deepness of Response to Osimertinib in Patients with Metastatic Non-Small Cell Lung Cancer: An Exploratory Analysis.

Authors: Bronte, Giuseppe Carnevale, Aldo Ciancetta, Antonella et al.

Source: Journal of Clinical Medicine. Feb2026, Vol. 15 Issue 3, p944. 13p.

Clinical Impact of Baseline ctDNA RAS / BRAF Mutations on Conversion Surgery and Outcomes in First-Line Anti-EGFR Therapy for Advanced Colorectal Cancer.

Authors: Yamada, Takeshi Nagasaka, Takeshi Matsuhashi, Nobuhisa et al.

Source: Cancers. Jun2026, Vol. 18 Issue 11, p1688. 13p.

Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Study †.

Authors: Deliktaş Onur, İlknur Doğan, Mutlu Öztürk, Mehmet Akif et al.

Source: Current Oncology. Nov2025, Vol. 32 Issue 11, p639. 14p.

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2025.

Authors: Ahmed, Arwa Mercier, Stéphanie L. Ramjeesingh, Ravi et al.

Source: Current Oncology. Apr2026, Vol. 33 Issue 4, p228. 26p.

Clinicopathological Features of Right vs. Left Colorectal Carcinomas: Do the Differences Really Matter?

Authors: Jurescu, Aura Dema, Alis Tăban, Sorina et al.

Source: Life (2075-1729). Feb2026, Vol. 16 Issue 2, p242. 16p.

Real-World Evidence from a Large German Outpatient Database for Oncology Research: A Narrative Review.

Authors: Kostev, Karel Konrad, Marcel Krieg, Andreas et al.

Source: Cancers. Jun2026, Vol. 18 Issue 11, p1747. 14p.

The Role of Computed Tomography-Determined Total Tumor Volume at Baseline in Predicting Outcomes of Patients with Locally Advanced Unresectable or Metastatic Pancreatic Ductal Adenocarcinoma.

Authors: Moujaes, Elissar Dupont, Jules Lawrance, Littisha et al.

Source: Cancers. Jan2026, Vol. 18 Issue 1, p20. 16p.

BRAF V600E and Non-V600E Mutations in RAS Wild-Type Metastatic Colorectal Cancer: Prognostic and Therapeutic Insights from a Nationwide, Multicenter, Observational Study (J-BROS).

Authors: Taniguchi, Hiroya Uehara, Kay Ishikawa, Toshiaki et al.

Source: Cancers. Feb2025, Vol. 17 Issue 3, p399. 15p.

Analysis of Colorectal Cancer Gene Mutations and Application of Long Blocker Displacement Amplification Technology for High-Throughput Mutation Detection.

Authors: Lu, Ping Su, Xinglei Leong, Sirui et al.

Source: Biosensors (2079-6374); May2025, Vol. 15 Issue 5, p308, 14p

Development of an APC and TP53-based duplex sequencing assay to positively predict colorectal cancer response to anti-EGFR therapy.

Authors: Yang, Mingli Schell, Michael J. Salk, Jesse J. et al.

Source: Cellular Oncology (2211-3428). Feb2026, Vol. 49 Issue 1, p1-19. 19p.

FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG).

Authors: Kalem, Ali Kus, Tulay Sahin, Taha Koray et al.

Source: Cancers. Sep2025, Vol. 17 Issue 17, p2730. 17p.

Patients with Colorectal Cancer and BRAF V600E -Mutation in Argentina: A Real-World Study—The EMOGI-CRC01 Study.

Authors: Catani, Greta Kim, Stefano Waisberg, Federico et al.

Source: Cancers. Mar2025, Vol. 17 Issue 6, p1007. 14p.

Retrospective Analysis of Regorafenib Efficiency in Treatment of Metastatic Colorectal Cancer—Experience of Two Polish Comprehensive Cancer Centers.

Authors: Grabiec, Magdalena Raźniewska, Dominika Kałużewski, Tadeusz et al.

Source: Journal of Clinical Medicine. Jan2026, Vol. 15 Issue 1, p332. 10p.

KRAS G12A Identifies a High-Risk Subset in Resected Stage II–III Colorectal Cancer.

Authors: Momma, Tomoyuki Okayama, Hirokazu Hayashishita, Sohei et al.

Source: Cancers. Nov2025, Vol. 17 Issue 22, p3599. 11p.

Genetic, Epidemiological, Clinical, and Therapeutic Trajectories in Colon and Rectal Cancers.

Authors: Capuozzo, Maurizio Picone, Carmine Sabbatino, Francesco et al.

Source: Cancers. Nov2025, Vol. 17 Issue 21, p3438. 44p.

Precision Targeting of KRAS -Mutant Cancers: Beyond G12C Toward G12D and Pan-RAS Therapeutic Strategies.

Authors: Kano, Yoshihito¹ (AUTHOR)

Source: International Journal of Molecular Sciences. Jul2026, Vol. 27 Issue 13, p5796. 21p.

Determinants of Colorectal Cancer: An Integrative Immunometabolic Framework Linking Biomarkers, Therapy, and the Diet–Microbiota Axis.

Authors: Aguiari, Gianluca Bianchi, Nicoletta Franzese, Ornella

Source: Cells (2073-4409). Jun2026, Vol. 15 Issue 12, p1074. 73p.

Colorectal Cancer: Current and Future Therapeutic Approaches and Related Technologies Addressing Multidrug Strategies Against Multiple Level Resistance Mechanisms.

Authors: Puzzo, Marianna De Santo, Marzia Morelli, Catia et al.

Source: International Journal of Molecular Sciences. Feb2025, Vol. 26 Issue 3, p1313. 23p.

KRAS Mutations in Colorectal Adenocarcinoma: Incidence and Association with Histological Features with Particular Reference to Gly12Asp in a Multicenter GIPAD Real-World Study.

Authors: Parente, Paola Angerilli, Valentina Grillo, Federica et al.

Source: Cancers. Sep2025, Vol. 17 Issue 17, p2721. 14p.